EUS-RFA for Inoperable Pancreatic Ductal Adenocarcinoma.
Status:
Withdrawn
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
This study will assess if endoscopic ultrasound radiofrequency application in patients with
inoperable pancreatic cancer and chemotherapy confers survival benefit when compared to
patients receiving best medical care and chemotherapy .